AV

Atul Vijaykumar Ganjewar

Active Director Director DIN 06474772
DIN 06474772 First appointment Mar 2013 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Mar 2013
Shareholding value •••• Premium profile

About Atul Vijaykumar Ganjewar

Data last updated:

Atul Vijaykumar Ganjewar is a Director at Capitis Pharmaceuticals Private Limited (since 2013). The company operates in Pharma. Capitis Pharmaceuticals Private Limited reported revenue of ₹2.1 Lakh (FY 2022).

DIN 06474772
Primary Designation Director
Industry Pharma
First Appointment 16 Mar 2013
Oldest Company Age 13 yrs
Largest company Capitis Pharmaceuticals Private Limited · ₹2.1 Lakh (FY 2022)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director16 Mar 20132013₹2.1 Lakh (FY 2022)Active

Board colleagues of Atul Vijaykumar Ganjewar

Directorship timeline

Open interactive timeline →
Capitis Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Atul Vijaykumar Ganjewar

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Atul Vijaykumar Ganjewar

Atul Vijaykumar Ganjewar currently holds 1 directorship: Capitis Pharmaceuticals Private Limited (Director, since 16 Mar 2013, revenue ₹2.1 Lakh (FY 2022)).

Atul Vijaykumar Ganjewar was first appointed on 16 Mar 2013 as Director at Capitis Pharmaceuticals Private Limited.

The current boards of Atul Vijaykumar Ganjewar's companies include Prashant Vijaykumar Ganjewar (Capitis Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available